Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocardial Lipid and Glycogen Metabolism & Cardiac Function in Patients With Impaired Glucose Tolerance or Type 2 Diabetes Mellitus and Calcium Sensing Receptor Mutations - A Cross Sectional Magnetic Resonance Spectroscopy and Imaging Study

NCT02023489 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocardial Lipid and Glycogen Metabolism & Cardiac Function in Patients With Impaired Glucose Tolerance or Type 2 Diabetes Mellitus and Calcium Sensing Receptor Mutations - A Cross Sectional Magnetic Resonance Spectroscopy and Imaging Study
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2013
Completion date
July 31, 2018
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familiar hypocalcuric hypercalcemia, healthy volunteers, prediabetes (insulin resistance, impaired glucose tolerance), type 1 diabetes mellitus, type 2 diabetes mellitus